A clinical trial comparing GHK-Cu to Matrixyl 3000 (one of the most popular anti-aging peptide ingredients in skincare) showed GHK-Cu produced a 55.8% reduction in wrinkle volume compared to control and a 31.6% reduction compared to Matrixyl 3000 itself
Brussels, Belgium: European Parliament
BPC-157 accelerates healing but cannot regenerate severely degenerated structures, overcome major structural abnormalities, or replace the need for rehabilitation
The easiest math, and the one most people pick, is 10mg/mL: it makes every standard dose land on a round insulin-unit number
Yes, because BPC-157 is an experimental compound intended for therapeutic use, it should only be used under the supervision of a licensed healthcare provider
no largescale clinical trials have been completed for TB500 specifically [13]